RemeGen secures approval in China for Telitacicept in treating generalised myasthenia gravis

Sanofi acquires DR-0201 from Dren Bio to expand immunology pipeline

Celltrion announces FDA interchangeability designation for all YUFLYMA's approved dosage forms and strengths

InnoCare reports first patient dosed in Phase II/III vitiligo trial

First participant dosed in second head-to-head Phase 3 study of mazdutide versus semaglutide in China

AB Science reports masitinib shows neuroprotective potential in preclinical model of neurodegeneration

Hemogenyx Pharmaceuticals expands HG-CT-1 trial to include paediatric AML patients

CARsgen reports positive preliminary clinical data for CT0596 in R/R MM

RTW Biotech portfolio company Jade Biosciences merges with Aerovate Therapeutics

Diamyd Medical to receive European patent for insulin antigen treatment targeting autoimmune diabetes

Innovent's limertinib receives Chinese regulatory approval for first-line treatment of lung cancer

InnoCare receives NMPA approval for orelabrutinib as first-line treatment for CLL/SLL in China

Sanofi invests EUR15m in Innate Pharma to strengthen strategic partnership

SynAct Pharma secures US patent allowance for resomelagon combination therapy in rheumatoid arthritis

NS Pharma's NS-229 granted US FDA Orphan Drug Designation for treatment of eosinophilic granulomatosis with polyangiitis